Assignee
MERCK CANADA INC
CA·5 granted patents·1 pending application·4 citations·filing 2006–2015
Top patents by PatentIndex Score
6 records- 0174US8003661B2Naphthalene and quinoline sulfonylurea derivatives as EP4 receptor antagonistsMERCK CANADA INC·Filed 2008·Granted Aug 23, 2011·2 cites·14 claims
- 0273US8013159B2Quinoline derivatives as EP4 antagonistsMERCK CANADA INC·Filed 2006·Granted Sep 6, 2011·2 cites·17 claims
- 0346US8343968B2Case of renin inhibitorsMERCK CANADA INC·Filed 2008·Granted Jan 1, 2013·0 cites·15 claims
- 0445US2013296382A1Non-nucleoside reverse transcriptase inhibitorsMERCK CANADA INC·Filed 2013·Application pending·0 cites
- 0536US9994587B2HIV protease inhibitorsMERCK CANADA INC·Filed 2015·Granted Jun 12, 2018·0 cites·17 claims
- 0634US8383643B2Spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturaseMERCK CANADA INC·Filed 2010·Granted Feb 26, 2013·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when MERCK CANADA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →